Department of Pathology, University of Cambridge, Cambridge, UK; VIB Center for Brain and Disease Research, Leuven, Belgium; KU Leuven, University of Leuven, Department of Microbiology and Immunology, Leuven, Belgium; Babraham Institute, Babraham Research Campus, Cambridge, UK.
Babraham Institute, Babraham Research Campus, Cambridge, UK.
Immunity. 2024 Jul 9;57(7):1586-1602.e10. doi: 10.1016/j.immuni.2024.05.023. Epub 2024 Jun 18.
The tissues are the site of many important immunological reactions, yet how the immune system is controlled at these sites remains opaque. Recent studies have identified Foxp3 regulatory T (Treg) cells in non-lymphoid tissues with unique characteristics compared with lymphoid Treg cells. However, tissue Treg cells have not been considered holistically across tissues. Here, we performed a systematic analysis of the Treg cell population residing in non-lymphoid organs throughout the body, revealing shared phenotypes, transient residency, and common molecular dependencies. Tissue Treg cells from different non-lymphoid organs shared T cell receptor (TCR) sequences, with functional capacity to drive multi-tissue Treg cell entry and were tissue-agnostic on tissue homing. Together, these results demonstrate that the tissue-resident Treg cell pool in most non-lymphoid organs, other than the gut, is largely constituted by broadly self-reactive Treg cells, characterized by transient multi-tissue migration. This work suggests common regulatory mechanisms may allow pan-tissue Treg cells to safeguard homeostasis across the body.
组织是许多重要免疫反应的发生部位,但免疫系统如何在这些部位受到控制仍不清楚。最近的研究在非淋巴组织中鉴定出了 Foxp3+ 调节性 T(Treg)细胞,与淋巴组织中的 Treg 细胞相比具有独特的特征。然而,人们并没有对所有组织中的 Treg 细胞进行整体考虑。在这里,我们对全身非淋巴器官中驻留的 Treg 细胞群体进行了系统分析,揭示了它们的共同表型、短暂居留和共同的分子依赖性。来自不同非淋巴器官的组织 Treg 细胞共享 T 细胞受体(TCR)序列,具有驱动多组织 Treg 细胞进入的功能能力,并且在组织归巢方面没有组织特异性。这些结果表明,除肠道外,大多数非淋巴器官中的组织驻留 Treg 细胞池主要由广泛的自身反应性 Treg 细胞组成,其特征是短暂的多组织迁移。这项工作表明,共同的调节机制可能允许泛组织 Treg 细胞在整个身体中维持内稳态。
Immunol Rev. 2014-5
Eur J Immunol. 2011-10-18
Nat Rev Immunol. 2021-9
Immunol Rev. 2025-9
iScience. 2025-7-23
Hum Vaccin Immunother. 2025-12
JHEP Rep. 2025-3-12
Biomedicines. 2025-5-11